The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C04 | Peripheral vasodilators | |
| 3 | C04A | Peripheral vasodilators | |
| 4 | C04AD | Purine derivatives |
| Code | Title | |
|---|---|---|
| C04AD01 | Pentifylline | |
| C04AD02 | Xantinol nicotinate | |
| C04AD03 | Pentoxifylline | |
| C04AD04 | Etofylline nicotinate |
| Active Ingredient | Description | |
|---|---|---|
| Pentifylline |
|
|
| Pentoxifylline |
Pentoxifylline has been shown to increase leukocyte deformability and to inhibit neutrophil adhesion and activation. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| TRENTAL 400 Modified release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |